1 / 9

Global Erectile Dysfunction Drugs Market Forecast upto 2024

Erectile dysfunction (ED) refers to the condition in which a male finds it difficult to get or maintain a firm enough erection to be able to have sex or other sexual activities. However, ED is of concern only if the person is not satisfied with his sexual performance on a regular basis. There are many treatments available for ED and most individuals find a solution that works for them. One such solution is oral therapy and it is considered a standard method of treatment. For cases where the oral therapy doesn’t work, individuals look out for alternatives or substitutes.

infoholicresearch
Download Presentation

Global Erectile Dysfunction Drugs Market Forecast upto 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Erectile Dysfunction Drugs Market Report Forecasts to 2024 Global Erectile Dysfunction Drugs Market Drivers, Opportunities, Trends, & Forecasts 2018 - 2024 https://www.infoholicresearch.com/report/erectile-dysfunction-drugs-market-forecast-2024/

  2. Report Overview Erectile dysfunction (ED) refers to the condition in which a male finds it difficult to get or maintain a firm enough erection to be able to have sex or other sexual activities. However, ED is of concern only if the person is not satisfied with his sexual performance on a regular basis. There are many treatments available for ED and most of individuals find a solution that work for them. One such solution is oral therapy and it is considered a standard method of treatment. For cases where the oral therapy don’t work, individuals look out for alternatives or substitutes. To evaluate the overall prevalence and determine the severity of ED across the globe, meta-analysis helps to determine the rationale for understanding the number of men around the globe effected with ED. The research is based on many assumptions. The data analysis below will highlight the key aspects. Buy Complete Report: https://www.infoholicresearch.com/report/erectile-dysfunction-drugs-market-forecast-2024/

  3. Key Players The market is dominated by Pfizer, Eli Lilly, Bayer, Meda Pharmaceuticals (Mylan N.V), Apricus Biosciences, and VIVUS. These pharmaceutical companies have the maximum revenue generation in the global erectile dysfunction drugs market. Market Analysis: ` The Global Erectile Dysfunction Drugs Market is estimated to witness a CAGR of -9.3% during the forecast period 2018–2024. The market is analyzed based on two segments namely product type and regions. 102 Pages|41 Tables |57 Charts |4 Companies |10 Enquiry Hours Get Sample Report https://www.infoholicresearch.com/request-a-sample-report/?repid=9837

  4. 10% Free Customization On This Report • https://www.infoholicresearch.com/request-a-sample-report/?repid=9837 • https://www.infoholicresearch.com/engage-with-analyst/?repid=9837 • https://www.infoholicresearch.com/customize-sample/?repid=9837 • https://www.infoholicresearch.com/enquiry-before-buying/?repid=9837

  5. Competitive Analysis The global erectile dysfunction drugs market has immense growth opportunities in both developed and developing regions. The patent expiry and development of ED drugs by many small, local, and regional players have disrupted the market size. Most of the companies have received patent drug information and have started developing generic drugs, which are almost in the final stages of completion. This means that most of the pure play vendors have already started research and development on ED drugs and is waiting for the date to coincide with the expiry of the patented drugs in the market. As a result, the major decline in the market is due to the introduction of generic drugs in the market. The fall of leading brands in the market has seen a decline since past few years. For instance, Viagra by Pfizer saw a drastic decline from $1,297 million in 2015 to $823 million in 2017. This fall in revenue has slowed down the sales of branded products in the market. The market has significant competition and possesses a strong financial incentive for the development of new and generic drugs for treating ED. Some of the leading drugs have given their rights for developing generic drugs. However, there are some companies that still have their product and are planning to come up with adjacent products that will increase their sales in the coming years. The most prominent brands in the market right now are Sildenafil citrate (marketed and sold by Pfizer as Viagra), Tadalafil (marketed and sold by Eli Lilly as Cialis), Vardenafil (marketed and sold by GlaxoSmith-Kline as Levitra), and Avanafil (sold in the US by Metuchen Pharmaceuticals, LLC as Stendra and sold in Europe and New Zealand by The Menarini Group as Spedra).

  6. Methodology Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps: Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services. Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

  7. About Infoholic Research Infoholic Research(https://www.infoholicresearch.com/)is a global market research and consulting organization providing strategic and high-level market intelligence in emerging and niche markets in Healthcare, ICT, Semiconductors, Chemicals & Materials domain. We aim at delivering high-quality results to our clients providing them with in-depth industry insights to identify new business opportunities and nurture their business strategies. Our team of analysts spanning verticals such as ICT, Healthcare, Chemicals and Semiconductors creates extensive Market Research reports every month covering market trends and dynamics envisioning the road ahead. We also have a Newsletter wherein we keep on featuring guest columns from domain experts, tête-à-tête with leaders and likewise. Additionally, our insightful blogs and articles truly keep the readers hooked. You may also send in your requests for getting our analysts’ viewpoints in specific areas of Healthcare, ICT, Chemicals & Materials, and Semiconductors to validate a certain market trend/ insight or finding. Please let me know how we both can create a cohesive quotient and associate for creating a win-win situation for both of us. https://www.infoholicresearch.com/report/erectile-dysfunction-drugs-market-forecast-2024/

  8. Contact Us Infoholic Research45/1, Residency Road Cross,5th Floor, Leo Shopping Complex, Bengaluru – 560025, IndiaEmail: sales@infoholicresearch.com Linkedin:https://www.linkedin.com/company/infoholic-research/ https://www.infoholicresearch.com/report/erectile-dysfunction-drugs-market-forecast-2024/

More Related